Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sanofi SA (SNY) vs Financial Select Sector SPDR Fund (XLF) Price & Performance

Sanofi SATrade
Financial Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Sanofi SA vs Financial Select Sector SPDR Fund — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Financial Select Sector SPDR Fund trades at $56.07. The key difference: Sanofi SA pays a 5.5% dividend while Financial Select Sector SPDR Fund pays none, and Financial Select Sector SPDR Fund is trading nearer its 52-week high, Sanofi SA nearer its low. Which is the better fit depends on your goals.

SNYXLF
Market Cap
$104.83B
Sector
Health
52-Week High
$52.34$56.75
52-Week Low
$41.33$47.80
Enterprise Value
$121.32B
Dividend Yield
5.5%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY

About Financial Select Sector SPDR Fund

The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.

Read more on XLF